| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |